16.11
price down icon2.33%   -0.385
after-market アフターアワーズ: 16.11 -0.005 -0.03%
loading

Liquidia Corp (LQDA) 最新ニュース

pulisher
Feb 12, 2025

Bleakley Financial Group LLC Lowers Stock Position in Liquidia Co. (NASDAQ:LQDA) - Defense World

Feb 12, 2025
pulisher
Feb 10, 2025

The Attractiveness of Investing In Liquidia Corp (LQDA) is Growing - Knox Daily

Feb 10, 2025
pulisher
Feb 08, 2025

Liquidia Co. (NASDAQ:LQDA) Receives $25.38 Average Price Target from Brokerages - MarketBeat

Feb 08, 2025
pulisher
Feb 08, 2025

Liquidia Corp's chief business officer sells $6,319 in stock - MSN

Feb 08, 2025
pulisher
Feb 07, 2025

Life Sciences Group Of The Year: Cooley - Law360

Feb 07, 2025
pulisher
Feb 06, 2025

Stock Performance Spotlight: Liquidia Corp (LQDA) Ends the Day at 15.74, Up by 3.89 - The Dwinnex

Feb 06, 2025
pulisher
Feb 06, 2025

Liquidia Corp.: We Have Exposure To The Upside Now - Seeking Alpha

Feb 06, 2025
pulisher
Feb 06, 2025

Liquidia Corp (LQDA) stock on the rise: An overview - US Post News

Feb 06, 2025
pulisher
Feb 04, 2025

This trade activity should not be overlooked: Liquidia Corp (LQDA) - SETE News

Feb 04, 2025
pulisher
Feb 04, 2025

Liquidia Corp [LQDA] Investment Appeal on the Rise - Knox Daily

Feb 04, 2025
pulisher
Jan 31, 2025

Liquidia Corporation's Long-Running Saga Is Coming To An End (NASDAQ:LQDA) - Seeking Alpha

Jan 31, 2025
pulisher
Jan 25, 2025

Liquidia Corp's chief medical officer sells $31,785 in stock - MSN

Jan 25, 2025
pulisher
Jan 24, 2025

Liquidia Co. (NASDAQ:LQDA) Insider Sells $31,785.00 in Stock - MarketBeat

Jan 24, 2025
pulisher
Jan 23, 2025

Liquidia Corp's chief medical officer sells $31,785 in stock By Investing.com - Investing.com UK

Jan 23, 2025
pulisher
Jan 22, 2025

Liquidia Technologies (LQDA) Moves 5.7% Higher: Will This Strength Last? - Yahoo Finance

Jan 22, 2025
pulisher
Jan 15, 2025

Barclays PLC Purchases 72,591 Shares of Liquidia Co. (NASDAQ:LQDA) - Defense World

Jan 15, 2025
pulisher
Jan 14, 2025

Liquidia Corp CFO Michael Kaseta sells shares worth $275,298 By Investing.com - Investing.com Australia

Jan 14, 2025
pulisher
Jan 14, 2025

Rajeev Saggar Sells 6,249 Shares of Liquidia Co. (NASDAQ:LQDA) Stock - MarketBeat

Jan 14, 2025
pulisher
Jan 14, 2025

Roger Jeffs Sells 22,343 Shares of Liquidia Co. (NASDAQ:LQDA) Stock - MarketBeat

Jan 14, 2025
pulisher
Jan 14, 2025

Liquidia Co. (NASDAQ:LQDA) General Counsel Russell Schundler Sells 16,393 Shares - MarketBeat

Jan 14, 2025
pulisher
Jan 14, 2025

Liquidia's chief medical officer Rajeev Saggar sells $73,613 in stock By Investing.com - Investing.com Australia

Jan 14, 2025
pulisher
Jan 14, 2025

Liquidia's chief commercial officer sells shares worth $98,504 By Investing.com - Investing.com Australia

Jan 14, 2025
pulisher
Jan 14, 2025

Liquidia’s chief commercial officer sells shares worth $98,504 By Investing.com - Investing.com Nigeria

Jan 14, 2025
pulisher
Jan 14, 2025

Liquidia Corp chief business officer sells $56,650 in stock By Investing.com - Investing.com South Africa

Jan 14, 2025
pulisher
Jan 14, 2025

Liquidia's chief commercial officer sells shares worth $98,504 - Investing.com India

Jan 14, 2025
pulisher
Jan 14, 2025

Liquidia's chief medical officer Rajeev Saggar sells $73,613 in stock - Investing.com India

Jan 14, 2025
pulisher
Jan 14, 2025

Liquidia Corp general counsel sells shares worth $193,109 - Investing.com India

Jan 14, 2025
pulisher
Jan 14, 2025

Liquidia Corp chief business officer sells $56,650 in stock - Investing.com

Jan 14, 2025
pulisher
Jan 14, 2025

Liquidia Corp CFO Michael Kaseta sells shares worth $275,298 - Investing.com

Jan 14, 2025
pulisher
Jan 14, 2025

Liquidia Corp general counsel sells shares worth $193,109 By Investing.com - Investing.com UK

Jan 14, 2025
pulisher
Jan 14, 2025

Evolving Landscape of Cardiology Segment: Key Market Insights of Latest Published Rare Cardiovascular Diseases Report — Giant-Cell Arteritis, Pulmonary Arterial Hypertension, and Restrictive Cardiomyopathy | DelveInsight - GlobeNewswire Inc.

Jan 14, 2025
pulisher
Jan 12, 2025

Liquidia’s (LQDA) Buy Rating Reiterated at Needham & Company LLC - Defense World

Jan 12, 2025
pulisher
Jan 11, 2025

Analysts Set Liquidia Co. (NASDAQ:LQDA) Price Target at $25.38 - MarketBeat

Jan 11, 2025
pulisher
Jan 09, 2025

Liquidia's (LQDA) "Buy" Rating Reaffirmed at Needham & Company LLC - MarketBeat

Jan 09, 2025
pulisher
Jan 09, 2025

Breaking Down Liquidia: 4 Analysts Share Their Views - Benzinga

Jan 09, 2025
pulisher
Jan 08, 2025

Liquidia Corporation to Present at 43rd Annual J.P. Morgan Healthcare Conference - Yahoo Finance

Jan 08, 2025
pulisher
Jan 08, 2025

Liquidia CEO to Present at J.P. Morgan Healthcare Conference 2025 in San Francisco - StockTitan

Jan 08, 2025
pulisher
Jan 07, 2025

Yutrepia's Launch: A Catalyst for Liquidia (LQDA) - substack.com

Jan 07, 2025
pulisher
Jan 01, 2025

Liquidia Co. (NASDAQ:LQDA) Shares Sold by Geode Capital Management LLC - MarketBeat

Jan 01, 2025
pulisher
Dec 31, 2024

Barclays PLC Buys 72,591 Shares of Liquidia Co. (NASDAQ:LQDA) - MarketBeat

Dec 31, 2024
pulisher
Dec 31, 2024

Barclays PLC Boosts Stock Position in Liquidia Co. (NASDAQ:LQDA) - Defense World

Dec 31, 2024
pulisher
Dec 27, 2024

Jim Cramer’s Hidden Gem: Why Liquidia Corporation (LQDA) Is the Undervalued Stock You Need to Know - Insider Monkey

Dec 27, 2024
pulisher
Dec 24, 2024

State Street Corp Decreases Stock Holdings in Liquidia Co. (NASDAQ:LQDA) - Defense World

Dec 24, 2024
pulisher
Dec 24, 2024

State Street Corp Has $21.75 Million Holdings in Liquidia Co. (NASDAQ:LQDA) - MarketBeat

Dec 24, 2024
pulisher
Dec 23, 2024

Liquidia (NASDAQ:LQDA) Research Coverage Started at Wells Fargo & Company - Defense World

Dec 23, 2024
pulisher
Dec 20, 2024

Wells Fargo & Company Initiates Coverage on Liquidia (NASDAQ:LQDA) - MarketBeat

Dec 20, 2024
pulisher
Dec 20, 2024

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $833,000 Stake in Liquidia Co. (NASDAQ:LQDA) - Defense World

Dec 20, 2024
$33.42
price up icon 0.27%
$81.06
price down icon 3.05%
$361.10
price down icon 1.70%
$22.12
price down icon 4.08%
biotechnology ONC
$255.37
price up icon 4.57%
$120.01
price up icon 1.81%
大文字化:     |  ボリューム (24 時間):